Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review Malvina HoxhaVisar MalajBruno Zappacosta Systematic Review Open access 27 January 2024 Pages: 147 - 170
A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma Fei Fei LiuMeaghan BartlettSamantha Craigie Systematic Review Open access 10 January 2024 Pages: 171 - 190
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models Tim ReasonWilliam RawlinsonSven Klijn Original Research Article Open access 10 February 2024 Pages: 191 - 203
Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models Tim ReasonEmma BenbowBill Malcolm Original Research Article Open access 10 February 2024 Pages: 205 - 220
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals Jose Luis CallejaJaime EspinAdam Igloi-Nagy Original Research Article Open access 15 December 2023 Pages: 221 - 233
Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50–85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study Andrew J. GoldbergEkaterina Bordeathe TARVA Study Group Original Research Article Open access 08 January 2024 Pages: 235 - 249
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy Elvio Emanuele RossiniCarlotta GaleoneClaudio Jommi Original Research Article Open access 16 January 2024 Pages: 251 - 261
Health State Utilities Associated with False-Positive Cancer Screening Results Louis S. MatzaTimothy A. HowellKaren C. Chung Original Research Article Open access 08 January 2024 Pages: 263 - 276
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden Maria PolyzoiMattias EkmanRobert Hettle Original Research Article Open access 13 December 2023 Pages: 277 - 289
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain Rosa María Romero JiménezPedro Herranz PintoFrancisco José Rebollo Laserna Original Research Article Open access 18 January 2024 Pages: 291 - 302
An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund Laura A. TriggMaxwell S. BarnishCaroline Farmer Original Research Article Open access 12 December 2023 Pages: 303 - 311
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark Milanne Maria Johanna GalekopCarin Uyl-de GrootWilliam Ken Redekop Original Research Article Open access 19 December 2023 Pages: 313 - 331
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies Ankita KaushikGeoffrey DusheikoRobert J. Wong Original Research Article Open access 03 January 2024 Pages: 333 - 343
Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy Elvio Emanuele RossiniCarlotta GaleoneClaudio Jommi Correction Open access 12 February 2024 Pages: 345 - 345